6505-01-104-6408 ( NDC00182-1679-01 , 01-7430 , NDC00009-0477-06 , TOLINASE )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-104-6408 | 6505 | 011046408 | TOLAZAMIDE TABLETS,USP | 3100 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| CSGS | ADMINISTRATION | ORAL |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 500.000 MILLIGRAMS TOLAZAMIDE ACTIVE INGREDIENT |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC00182-1679-01 | 63488 | A | 2 | 3 | 6 | 54 | |
| 01-7430 | 63488 | A | 2 | 3 | 6 | 54 | |
| NDC00009-0477-06 | 93703 | A | 2 | 3 | 6 | 54 | |
| TOLINASE | 93703 | A | 1 | 5 | 6 | 54 |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC00182-1679-01 | 63488 | GOLDLINE LABORATORIES INC. | A | A |
| 01-7430 | 63488 | GOLDLINE LABORATORIES INC. | A | A |
| NDC00009-0477-06 | 93703 | PHARMACIA & UPJOHN COMPANY | A | A |
| TOLINASE | 93703 | PHARMACIA & UPJOHN COMPANY | A | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| U | X | A | 1 | 12/07/1 | P | 3004909190 | 3100 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| VA | V | K | U/I CONTAINS 100 TT |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | U | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| VA | I | 0 | BT | M | U | V |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|